Neuro-Luminance and Dr. Henderson announce a new method of activating neuroplasticity and brain healing. We introduce the:
EXOMIND
EXOMIND by BTL is the latest breakthrough in neuromodulation technology – providing faster, safer, more comfortable, and more effective transcranial magnetic stimulation. EXOMIND is an FDA-approved, drug-free treatment that uses magnetic pulses to stimulate specific areas of the brain associated with mood, cognition, and overall mental function.
Over the course of several sessions, EXOMIND helps stimulate neuroplasticity, strengthening neural connections that support long-term improvements in mood, focus, and overall mental well-being.
Used in combination with LUMIT, EXOMIND has a synergistic amplifying effect on neuroplasticity, maximizing brain healing.
Mental Wellness
It Matters More Than Ever
Mental health is the leading health concern across North America, with 1 in 5 people facing emotional or behavioral challenges each year. Whether you’re dealing with anxiety, stress, depression, or simply feeling mentally drained, EXOMIND offers a way to regain clarity, restore balance, and take back control of your well-being.
Make mental wellness your own #1 concern. Even if you feel like you are mentally OK…Can you imagine a better you?
Picture this: you’re calm, laser-focused, and fully in control of your life. You’re not at the mercy of stress, anxiety, or feeling overwhelmed — you’re driving the ship. EXOMIND is the tool to help you break through, reclaim your power, and create the emotional strength you deserve. Don’t wait for change — make it happen. Try EXOMIND today and take command of your mind and your future.
Why EXOMIND?
Unlike traditional TMS devices, EXOMIND by BTL represents the latest breakthrough in neuromodulation technology—offering faster, more comfortable, and more effective treatments than ever before. With its patented, cutting-edge precision, EXOMIND optimizes treatment to target the brain regions most responsible for your unique symptoms, leading to better outcomes in fewer sessions.
Using advanced ExoTMS™ technology, EXOMIND comfortably stimulates key areas of the brain involved in emotional regulation, cognitive function, and self-control. By stimulating neural pathways and activating neuroplasticity, it helps restore healthy brain activity and enhances neural connectivity.
FDA-Cleared for the Treatment of Depression
EXOMIND is FDA-cleared for the treatment of depression in the U.S. It’s a safe, non-invasive, and medication-free option to help improve mental wellness and emotional well-being.
EXOMIND represents a leap forward in transcranial magnetic stimulation (TMS). It utilizes a more powerful magnet than typical TMS devices. EXOMIND also uses a patented magnetic waveform that makes TMS comfortable and painless. And fast! Rather than sitting through 40 treatments lasting one hour or more over 8-10 weeks, EXOMIND’s FDA-approved treatment for depression is accomplished in 6 treatments. In addition, the treatments take less than 30 minutes.
Imagine the difference. Instead of losing two or more hours per day for 8-10 weeks with traditional TMS – disrupting job and family life, you can get revolutionary treatment for your brain health in six treatments lasting less than 30 minutes. You could do this over your lunch break!
What does EXOMIND feel like?
During an EXOMIND TMS session, you will be awake and comfortably reclined in a relaxing treatment environment. The device delivers gentle magnetic pulses to targeted areas of your brain, similar to the sensation of a light tapping or mild tingling on your scalp. Most patients describe it as painless or mildly stimulating and easily tolerable, with no need for anesthesia or sedation. The discomfort and loud noises associated with traditional TMS are absent with the patented ExoTMS™ technology.
Mentally, many individuals report a sense of clarity, focus, and relaxation after treatment. Some feel an immediate improvement in mood and energy, while for others, benefits build gradually over several sessions. Unlike medication, TMS does not cause systemic side effects like drowsiness, weight gain, or brain fog, making it a safe and effective alternative for mental wellness. You can immediately resume your daily activities, including work, driving, and exercise—there’s no recovery time needed.
Like other modalities offered at Neuro-Luminance Brain Health Centers, EXOMIND stimulates neuroplasticity. Because EXOMIND stimulates neuroplasticity by a unique mechanism, combining it with other methods of inducing neuroplasticity leads to a synergistic benefit. In other words, one plus one equals three!
LUMIT therapy activates neuroplasticity very powerfully via stimulation of the mitochondria. Ketamine infusion therapy activates neuroplasticity via the NMDA receptor. EXOMIND stimulates neuroplasticity via upregulation of AMPA and NMDA receptors.
The Science of Neuroplasticity with EXOMIND
TMS has been shown to activate neuroplasticity by a mechanism distinct from that of infrared light treatments. TMS increases AMPA receptors and fosters NMDA receptor activation. This leads to an increase in BDNF (brain-derived neurotrophic factor) which is the key driver of neuroplasticity in the adult brain. TMS also facilitates the expression of a protein called MeCP2 which further induces BDNF. In addition, TMS has anti-inflammatory properties by altering glial cell responses and upregulating key anti-inflammatory proteins.
Infrared light delivered to the mitochondria by the LUMIT technology powerfully increases BDNF by a distinct mechanism. When you combine these technologies, a synergistic effect on neuroplasticity occurs which is more than just the additive effects. The combination of these two modalities yields a benefit greater than just the sum of the two parts. One + one = three!
![[Diagram illustrating the scientific principles behind EXOMIND's treatment, showing how infrared light and transcranial magnetic stimulation (TMS) enhance BDNF production and release from neurons]](https://i0.wp.com/neuro-luminance.com/wp-content/uploads/2025/06/exomind-science.jpg?fit=792%2C612&ssl=1)
Is EXOMIND right for me?
EXOMIND is FDA-cleared for the treatment of depression in the U.S. Yet, EXOMIND is much more than an antidepressant. It is a safe, non-invasive, and medication-free option to help improve mental wellness and emotional well-being. It is also an adjunct treatment to enhance neuroplasticity and brain healing.
What it treats
- Brain fog
- Difficulty concentrating
- Mood changes
- Irritability
- Poor memory
- Difficulty sleeping
- Long COVID
- Anxiety
- Depression
- Post-concussive symptoms
- Brain injury
- PTSD
- Parkinson’s disease
- Mild cognitive impairment and dementia
- ADHD
- Binge eating disorders
- Addictive behaviors
More than a treatment for depression, EXOMIND is a pathway to mental vitality and longevity.
EXOMIND is designed to support anyone seeking better mental performance and emotional balance. Whether you’re managing stress, improving focus, or enhancing overall well-being, EXOMIND can help.
Ideal for People Who:
- Are professionals navigating high-pressure environments and feeling the effects of stress or burnout
- Are students aiming to boost concentration, memory, and mental sharpness
- Are parents juggling the demands of work, family, and self-care
- Simply want to feel more centered, focused, and in control every day
Clinically Proven Results with EXOMIND
EXOMIND’s technology has been FDA-cleared since 2008 and has helped millions worldwide improve their mental health.
Key Benefits
- Effective symptom relief for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
- Gentle and well-tolerated – most users experience only mild sensations like scalp tingling or a slight headache
- High success rates, especially for individuals who haven’t responded to traditional medications or therapies
What the Research Shows
- 90% of participants reported improved mental well-being and found the therapy comfortable with no adverse effects
- Of those starting with low mental well-being:
- 66.7% improved to a moderate level
- 16.7% improved to a high level
- Of those starting with moderate well-being:
- 52.4% improved to a high level
